However, after adjusting for other risk factors, the association of CD44 expression (aOR = 0.66, 95% CI: 0.10-4.26, P = 0.658) and CD24 expression (aOR = 0.09, 95% CI: 0.01-1.35, P = 0.081) with gastric cancer recurrence were still not significant. This evidence concerns the gene CD44 and gastric cancer.